EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Perrigo Co's enterprise value is $7,143 Mil.
Perrigo Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $4,203 Mil. Therefore, Perrigo Co's EV-to-Revenue for today is 1.70.
The historical rank and industry rank for Perrigo Co's EV-to-Revenue or its related term are showing as below:
PRGO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.4 Med: 3.15 Max: 7.89
Current: 1.7
During the past 13 years, the highest EV-to-Revenue of Perrigo Co was 7.89. The lowest was 1.40. And the median was 3.15.
PRGO's EV-to-Revenue is ranked better than 67.05% of 1032
companies
in the Drug Manufacturers industry
Industry Median: 2.61
vs PRGO: 1.70
As of today (2022-08-10), Perrigo Co's stock price is $41.78.
Perrigo Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $31.41. Therefore, Perrigo Co's PS Ratio for today is 1.33.
Perrigo Co EV-to-Revenue Historical Data
The historical data trend for Perrigo Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Perrigo Co Annual Data
Trend
Jun12
Jun13
Jun14
Jun15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
EV-to-Revenue
3.02
1.68
2.60
2.21
1.70
Perrigo Co Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
EV-to-Revenue
2.12
2.31
1.91
1.70
1.60
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Perrigo Co's EV-to-Revenue falls into.
Perrigo Co's current Enterprise Value is $7,143 Mil.
Perrigo Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,203 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co's share price for today is $41.78.
Perrigo Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $31.41.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Perrigo Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.21(0.51%) Volume: 5,540,335 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:PRGO has been successfully added to your 
